Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trialWinette T.A. van der Graaf, Peter Hohenberger, Jean‐Yves Blay et al.|The Lancet|2012Cited by 2.1k
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic TumorsBrandon D. Lawrence, Jonathan A. Fletcher, Antonio R. Pérez‐Atayde et al.|American Journal Of Pathology|2000Cited by 716
STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implicationsDavid A. Tuveson, George D. Demetri, Nicholas A. Willis et al.|Oncogene|2001Cited by 700
Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: An analysis of 26,758 casesJorge R. Toro, Susan S. Devesa, Lois B. Travis et al.|International Journal of Cancer|2006Cited by 680
KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal TumorsMarcia L. Lux, Jonathan A. Fletcher, Brian P. Rubin et al.|American Journal Of Pathology|2000Cited by 647